The initial meeting sets the stage for the series. Discussion topics will include the burden of HBV among children in the AFRO region, status of infant HepB vaccination beginning with a timely birth dose, triple (HIV, HBV, syphilis) elimination initiatives, the impact of the COVID-19 pandemic response on the routine infant immunization coverage, and updates on the status of Ministry of Health intentions related to HepB birth dose introduction and HBV research and technical assistance (TA) to identify opportunities for collaboration across target countries.

Dates:

Part 1-Wednesday, March 17, 2021

• 8:00-11:00 Atlanta
• 12:00-15:00 Accra
• 13:00-16:00 Brazzaville, Paris
• 15:00-18:00 Addis Ababa

Part 2-Thursday, March 18, 2021

• 8:00-11:00 Atlanta
• 12:00-15:00 Accra
• 13:00-16:00 Brazzaville, Paris
• 15:00-18:00 Addis Ababa

Objectives met:

• Present updates from WHO AFRO, Gavi and the US CDC on HepB birth dose progress in the region.
• Map the current and upcoming projects related to HepB birth dose underway by Ministry of Health, research and TA partners

CDC, WHO, and the Coalition will provide an update on the latest evidence for introduction of HepB birth dose, the status of HepB birth dose programs globally and regionally, and current priorities for research and technical assistance. Research and technical partners will also provide an update on their ongoing activities. 

Expected outputs in the meeting report:   

• Profiles of MoH activities (intent to introduce) and key research and TA partners supporting introduction of HepB birth dose
• Framework for key opportunities and challenges related to introduction and scale-up and maintenance of HepB birth dose

More on the webinar series

Register here

Pre-meeting surveys:

English- TA/Research Partner Survey

English- EPI Manager/MOH Survey

French- TA/Research Partner Survey

French- EPI Manager/MOH Survey

Speaker Bios